Abstract | BACKGROUND AND OBJECTIVE: METHODS: Infants (6-12 weeks postnatal and bodyweight > 3 kg) with EA or CDH and GERD were randomized to receive a single dose of 1 mg/kg omeprazole rectally or orally. The primary outcome was the percentage of infants for whom omeprazole was effective according to predefined criteria for 24-h intraesophageal pH. Secondary outcomes were the percentages of time that gastric pH was < 3 or < 4, as well as the pharmacokinetic parameters. RESULTS: Seventeen infants, 4 with EA and 13 with CDH, were included. The proportion of infants for whom omeprazole was effective was 56% (5 of 9 infants) after rectal administration and 50% (4 of 8 infants) after oral administration. The total reflux time in minutes and percentages and the number of reflux episodes of pH < 4 decreased statistically significantly after both rectal and oral omeprazole administration. Rectal and oral administration of omeprazole resulted in similar serum exposure. CONCLUSIONS: A single rectal omeprazole dose (1 mg/kg) results in consistent increases in intraesophageal and gastric pH in infants with EA- or CDH-related GERD, similar to an oral dose. Considering the challenges with existing oral formulations, rectal omeprazole presents as an innovative, promising alternative for infants with pathological GERD. CLINICAL TRIAL REGISTER: ClinicalTrials.gov Identifier: NCT00226044.
|
Authors | Petra Bestebreurtje, Barbara A E de Koning, Nel Roeleveld, Catherijne A J Knibbe, Dick Tibboel, Bianca van Groen, Cees P van de Ven, Frans B Plötz, Saskia N de Wildt |
Journal | European journal of drug metabolism and pharmacokinetics
(Eur J Drug Metab Pharmacokinet)
Vol. 45
Issue 5
Pg. 635-643
(Oct 2020)
ISSN: 2107-0180 [Electronic] France |
PMID | 32594305
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Proton Pump Inhibitors
- Omeprazole
|
Topics |
- Administration, Oral
- Administration, Rectal
- Esophageal Atresia
(complications)
- Esophageal pH Monitoring
- Female
- Gastroesophageal Reflux
(drug therapy, etiology)
- Hernias, Diaphragmatic, Congenital
(complications)
- Humans
- Infant
- Male
- Omeprazole
(administration & dosage, pharmacokinetics)
- Pilot Projects
- Proton Pump Inhibitors
(administration & dosage, pharmacokinetics)
- Treatment Outcome
|